000			02002 a2200541 4500
005			20250513193241.0
264		0	_c20000104
008			200001s 0 0 eng d
022			_a0007-1188
024	7		_a10.1038/sj.bjp.0702785 _2doi
040			_aNLM _beng _cNLM
100	1		_aWang, C N
245	0	0	_aNepalolide A inhibits the expression of inducible nitric oxide synthase by modulating the degradation of IkappaB-alpha and IkappaB-beta in C6 glioma cells and rat primary astrocytes. _h[electronic resource]
260			_bBritish journal of pharmacology _cSep 1999
300			_a345-56 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAnthracenes _xpharmacology
650	0	4	_aAstrocytes _xdrug effects
650	0	4	_aBiotransformation _xdrug effects
650	0	4	_aBlotting, Western
650	0	4	_aBrain Neoplasms _xmetabolism
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aDNA-Binding Proteins _xmetabolism
650	0	4	_aDepression, Chemical
650	0	4	_aElectrophoresis
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aGlioma _xmetabolism
650	0	4	_aI-kappa B Proteins
650	0	4	_aInterferon-gamma _xantagonists & inhibitors
650	0	4	_aNF-KappaB Inhibitor alpha
650	0	4	_aNF-kappa B _xantagonists & inhibitors
650	0	4	_aNitric Oxide Synthase _xantagonists & inhibitors
650	0	4	_aNitric Oxide Synthase Type II
650	0	4	_aNitrites _xmetabolism
650	0	4	_aOligonucleotides _xmetabolism
650	0	4	_aPrecipitin Tests
650	0	4	_aRNA, Messenger _xbiosynthesis
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aRecombinant Proteins
700	1		_aShiao, Y J
700	1		_aLin, Y L
700	1		_aChen, C F
773	0		_tBritish journal of pharmacology _gvol. 128 _gno. 2 _gp. 345-56
856	4	0	_uhttps://doi.org/10.1038/sj.bjp.0702785 _zAvailable from publisher's website
999			_c10467511 _d10467511